Thomás Paiva Lima Dias

Dr. Thomás Paiva Lima Dias

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2026 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Open access
GSGabriel Siebiger
Gabriel Siebiger
AWAizhou Wang
Aizhou Wang
JYJenny Yune
Jenny Yune
JMJuan Montagne
Juan Montagne
GGGuillermo Garza
Guillermo Garza
MCMarcelo Cypel
Marcelo Cypel
Controlled hypothermic storage of donor organs at 10°C is an emergent clinical standard in lung transplantation due to its superior graft protective effects. Itaconate, a known regulator of cell immunometabolism, has been shown to be upregulated in donor lungs preserved at 10°C for extended periods of static storage versus on ice. We hypothesized that itaconate may be an active agent in donor graft protection against ischemia-reperfusion injury, rather than a byproduct of 10°C graft metabolism. We conducted cell-based screening of multiple formulations and concentrations of itaconate and its derivatives and identified 0.25 mM dimethyl itaconate as the most promising candidate for lung preservation. Lungs from Yorkshire pigs (n = 4/group) were randomized to be flushed with low potassium dextran solution ± 0.25 mM dimethyl itaconate, stored at 4°C for 36 hours to limit endogenous itaconate production, then assessed using ex-vivo lung perfusion. Lungs preserved with dimethyl itaconate had better function, as indicated by lower airway pressures, higher lung compliances, improved perfusate oxygenation, and less edema formation than controls. Perfusate pro-inflammatory cytokines were significantly lower with dimethyl itaconate. Tissue IκBζ levels declined, and dimethyl itaconate prevented tissue oxidative stress after reperfusion. High resolution respirometry indicated no inhibition of succinate dehydrogenase with dimethyl itaconate at 0.25 mM at either hypothermic or normothermic conditions. Dimethyl itaconate safely modulated inflammation and improved lung physiologic performance upon reperfusion, supporting itaconate's protective role in donor-lung preservation.

Verified
Journal Article
Open access
PDF file
Miguel Mascarenhas SaraivaMiguel Mascarenhas Saraiva
Miguel Mascarenhas Saraiva
GNGema Díaz Nuevo
Gema Díaz Nuevo
Sara LopesSara Lopes
Sara Lopes
JSJuan Puertas Sancho
Juan Puertas Sancho
CGCristina Lopez Garcia-Gallo
Cristina Lopez Garcia-Gallo
AMAdelino Leite Moreira
Adelino Leite Moreira
Background/Objectives: Accurate mediastinal and hilar lymph node (LN) assessment is central to lung cancer staging and treatment selection. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has become the standard minimally invasive procedure for mediastinal staging, enabling real-time identification, characterization and sampling of LNs. Although effective, this technique remains operator dependent, and subject to interobserver variability. This study aims to report the development of a Vision Transformer-based AI model for automatic LN detection and classification on EBUS images. Methods: A multicenter, multidevice, retrospective study, using EBUS images of three referral centers (Spain and Brazil). The dataset included images of patients with benign and malignant LNs. Bounding-box annotations were applied for LN localization, and LNs were classified as benign or malignant according to histopathologic reference standards. Detection performance was evaluated with mean average precision, at an intersection over union threshold of 0.5 (mAP50). Characterization performance was assessed using accuracy, sensitivity, specificity, and area under the receiver operating characteristic curve (AUROC). Results: The dataset included 6492 images from 27 patients, of whom 16 had malignant LNs. In the test set, the model achieved a mAP50 of 0.79 for LN detection. For malignant characterization, the model achieved an accuracy of 90.6%, sensitivity of 85.4%, and an AUROC of 0.938. Conclusions: The results of this study support the feasibility of AI-assisted EBUS interpretation for nodal staging workflows and raise the possibility that AI-assisted EBUS could enhance diagnostic performance, while reducing operator variability. Larger prospective studies are needed before clinical implementation.